Left Ventricular Hypertrophy Clinical Trial
Official title:
Impact of Physical Activity on Left Ventricular Mass and Lipid Metabolism in Healthy Female Volunteers Training for a Marathon
Prospective study on the structural and functional changes in the heart of adult women assessed by echocardiogram and in lipid metabolism that occur in response to physical training. Using echocardiogram we will characterize the early determinants of "athletic remodeling". We will also assess the effect of intense physical training on lipid metabolism, focus on HDL subspecies and function.
Left ventricular hypertrophy, defined as an increase in the mass of the left ventricle may
occur as a physiologic response to exercise (athletic remodeling aka "athletic heart"), but
is most frequently encountered as a pathological manifestation of cardiovascular disease. The
early determinants of athletic remodeling in the general population are largely unknown. In
order to longitudinally explore the early determinants of athletic remodeling, we will
recruit from the community, physically untrained women who have volunteered to run a
marathon. We will prospectively assess left ventricular mass and function by echocardiogram
during three consecutive stages/visits:
- Baseline: prior to starting intense physical training
- Trained: at the end of at least 12 week training period, prior to running the marathon.
- Post-marathon: 6 weeks after running the marathon.
In addition, exercise impacts lipid metabolism and short-term exercise is known to increase
HDL levels in plasma. Human HDL is structurally heterogeneous, comprising at least sixteen
discrete species. It has multiple functions, pertinent to cardiovascular medicine such as the
ability to accept effluxed cholesterol from the artery wall, culminating in sterol uptake in
the liver. This "reverse cholesterol transport pathway" is thought to prevent the
accumulation of cholesterol in the artery wall. We will assess the clinical and genetic
determinants of the HDL response to physical exercise.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
Completed |
NCT03332745 -
Mechanism of Decompensation Evaluation - Aortic Stenosis
|
||
Completed |
NCT03322319 -
Frequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose)
|
N/A | |
Completed |
NCT01951404 -
Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study
|
Phase 4 | |
Terminated |
NCT01188369 -
Effects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular Hypertrophy
|
Phase 4 | |
Completed |
NCT00344903 -
Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort
|
N/A | |
Completed |
NCT00518479 -
Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression
|
N/A | |
Completed |
NCT00001632 -
Investigation Into the Use of Ultrasound Technique in the Evaluation of Heart Disease
|
N/A | |
Completed |
NCT00001534 -
Long Term Effects of Enalapril and Losartan on Genetic Heart Disease
|
N/A | |
Suspended |
NCT03193073 -
Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient
|
N/A | |
Enrolling by invitation |
NCT05903313 -
A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
|
||
Recruiting |
NCT05646056 -
A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk
|
||
Completed |
NCT01455974 -
The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients
|
N/A | |
Active, not recruiting |
NCT00418041 -
Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)
|
N/A | |
Completed |
NCT00602004 -
Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan
|
N/A | |
Completed |
NCT00219141 -
Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension
|
Phase 3 | |
Completed |
NCT03666351 -
Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease
|
Phase 4 | |
Recruiting |
NCT05730309 -
Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy
|
N/A | |
Not yet recruiting |
NCT04022330 -
Protective Monocytes and Macrophages to Limit Decompensation and Heart Damaging
|
N/A | |
Recruiting |
NCT06169358 -
Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy
|